Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
0.00%
GROSS MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Bone Biologics Corporation
Market Cap
$850879.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$851149.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
Market Cap
$837084.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
4.91%
5Y Avg
3.27%
Market Cap
$874437.00
Gross Margin
N/A
TTM Avg
19.10%
3Y Avg
22.14%
5Y Avg
32.68%
Market Cap
$880215.00
Gross Margin
29.80%
TTM Avg
31.72%
3Y Avg
34.27%
5Y Avg
41.55%
Market Cap
$1.03M
Gross Margin
-1.87%
TTM Avg
-0.94%
3Y Avg
-0.47%
5Y Avg
-0.37%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bone Biologics Corporation (BBLG) | $850879.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Decoy Therapeutics Inc. (DCOY)vs › | $851149.00 | 0.00% | 0.00% | 0.00% | 16.67% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $837084.00 | 0.00% | 0.00% | 4.91% | 3.27% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $874437.00 | N/A | 19.10% | 22.14% | 32.68% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $880215.00 | 29.80% | 31.72% | 34.27% | 41.55% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Ridgetech, Inc. (RDGT)vs › | $791587.00 | N/A | 3.40% | 12.49% | 15.69% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -1.87% | -0.94% | -0.47% | -0.37% |
| CDT Equity Inc. (CDT)vs › | $668915.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-07-31 | 0.00% |
| 2014-04-30 | 0.00% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | 0.00% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 0.00% |
| 2013-01-31 | 0.00% |
| 2009-10-31 | 0.00% |
| 2009-01-31 | 0.00% |
| 2008-01-31 | 0.00% |
